Fig. 2. Relative anti-proliferative activity of TOTA and its derivatives against the breast MDA-MB-231 and colon HCT116 cancer cell lines. The mean percentages (%) at 10 μM as compared to untreated cells at 100% growth, i.e., the lower percentage numbers represent greater growth inhibition.